Orexin–corticotropin-releasing factor receptor heteromers in the ventral tegmental area as targets for cocaine

Journal of Neuroscience

Volumn 35, Issue 17, 2015, Pages 6639-6653

  Navarro, Gemma ^a   Quiroz, César ^b   Moreno Delgado, David ^a   Sierakowiak, Adam ^b   McDowell, Kimberly ^b   Moreno, Estefanía ^a   Rea, William ^b   Cai, Ning Sheng ^b   Aguinaga, David ^a   Howell, Lesley A ^c   Hausch, Felix ^d   Cortés, Antonio ^a   Mallol, Josefa ^a   Casadó, Vicent ^a   Lluís, Carme ^a   Canela, Enric I ^a   Ferré, Sergi ^b   McCormick, Peter J ^a,c  

^a UNIVERSITY OF BARCELONA   (Spain)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^c UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^d MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Cocaine; CRF receptor; GPCR heteromer; Orexin receptor; Sigma receptor

Indexed keywords

1 (2 METHYL 6 BENZOXAZOLYL) 3 (1,5 NAPHTHYRIDIN 4 YL)UREA; BETA ARRESTIN 2; COCAINE; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CYCLIC AMP; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OREXIN 1 RECEPTOR; OREXIN A; PROTEIN KINASE B; SIGMA OPIATE RECEPTOR; BETA ARRESTIN; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; DOPAMINE; DOPAMINE UPTAKE INHIBITOR; ONCOPROTEIN; OREXIN RECEPTOR; PROTEIN BINDING; RETINA S ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DOPAMINE RELEASE; DRUG SEEKING BEHAVIOR; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MALE; MOLECULAR CLONING; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PURIFICATION; RAT; SIGNAL TRANSDUCTION; VENTRAL TEGMENTUM; WESTERN BLOTTING; ANIMAL; CYTOLOGY; DENDRITE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; IN VITRO STUDY; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TIME;

ANIMALS; ARRESTINS; COCAINE; CYCLIC AMP; DENDRITES; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; IN VITRO TECHNIQUES; MALE; MAP KINASE SIGNALING SYSTEM; ONCOGENE PROTEIN V-AKT; OREXIN RECEPTORS; PHOSPHORYLATION; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; TIME FACTORS; VENTRAL TEGMENTAL AREA;

EID: 84929340828     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.4364-14.2015     Document Type: Article

References (43)

1. Akunne HC, Whetzel SZ, Wiley JN, Corbin AE, Ninteman FW, Tecle H, Pei Y, Pugsley TA, Heffner TG (1997) The pharmacology of the novel and selective sigma ligand, PD 144418. Neuropharmacology 36:51-62. CrossRef Medline
2. Azdad K, Gall D, Woods AS, Ledent C, Ferré S, Schiffmann SN (2009) Dopamine D2 and adenosine A2Areceptors regulate NMDA-mediated excitation in accum-bens neurons through A2A-D2 receptor heteromerization. Neuropsychopharmacology 34:972-986. CrossRef Medline
3. Blacktop JM, Seubert C, Baker DA, Ferda N, Lee G, Graf EN, Mantsch JR (2011) Augmented cocaine seeking in response to stress or CRF delivered into the ventral tegmental area following long-access self-administration is mediated by CRF receptor type 1 but not CRF receptor type 2. J Neurosci 31:11396-11403. CrossRef Medline
4. Borgland SL, Ungless MA, Bonci A (2010) Convergent actions of orexin/ hypocretin and CRF on dopamine neurons: emerging players in addiction. Brain Res 1314:139-144. CrossRef Medline
5. Boutrel B, Kenny PJ, Specio SE, Martin-Fardon R, Markou A, Koob GF, de Lecea L (2005) Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc Natl Acad Sci USA 102: 19168-19173. CrossRef Medline
6. Carriba P, Navarro G, Ciruela F, Ferré S, Casadó V, Agnati L, Cortés A, Mallol J, Fuxe K, Canela El, Lluís C, Franco R (2008) Detection of heteromerization of more than two proteins by sequential BRET-FRET. Nat Methods 5:727-233. CrossRef Medline
7. de Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE, Fukuhara C, Battenberg EL, Gautvik VT, Bartlett FS 2nd, Frankel WN, van den Pol AN, Bloom FE, Gautvik KM, Sutcliffe JG (1998) The hypocretins: hypo-thalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A 95:322-327. CrossRef Medline
8. Devigny C, Perez-Balderas F, Hoogeland B, Cuboni S, Wachtel R, Mauch CP, Webb KJ, Deussing JM, Hausch F (2011) Biomimetic screening of class-B G protein-coupled. J Am Chem Soc 133:8927-8933. CrossRef Medline
9. Ellis J, Pediani JD, Canals M, Milasta S, Milligan G (2006) Orexin-1 receptor-cannabinoid CB1 receptor heterodimerization results in both ligand-dependent and-independent coordinated alterations of receptor localization and function. J Biol Chem 281:38812-38824. CrossRef Medline
10. Ferré S, Baler R, Bouvier M, Caron MG, Devi LA, Durroux T, Fuxe K, George SR, Javitch JA, Lohse MJ, Mackie K, Milligan G, Pfleger KD, Pin JP, Volkow ND, Waldhoer M, Woods AS, Franco R (2009) Building a new conceptual framework for receptor heteromers. Nat Chem Biol 5:131-134. CrossRef Medline
11. Ferré S, Casadó V, Devi LA, Filizola M, Jockers R, Lohse MJ, Milligan G, Pin JP, Guitart X (2014) Protein-coupled receptor oligomerization revisited: functional and pharmacological perspectives. Pharmacol Rev 66:413-434. CrossRef Medline
12. Garcés-Ramírez L, Green JL, Hiranita T, Kopajtic TA, Mereu M, Thomas AM, Mesangeau C, Narayanan S, McCurdy CR, Katz JL, Tanda G (2011) Sigma receptor agonists: receptor binding and effects on mesolimbic dopamine neurotransmission assessed by microdialysis. Biol Psychiatry 69: 208-217. CrossRef Medline
13. Guitart X, Navarro G, Moreno E, Yano H, Cai NS, Sánchez-Soto M, Kumar-Barodia S, Naidu YT, Mallol J, Cortés A, Lluís C, Canela El, Casadó V, McCormick PJ, Ferré S (2014) Functional selectivity of allosteric interactions within GPCR oligomers: the dopamine D1-D3 receptor hetero-tetramer. Mol Pharmacol 86:417-429. CrossRef Medline
14. He SQ, Zhang ZN, Guan JS, Liu HR, Zhao B, Wang HB, Li Q, Yang H, Luo J, Li ZY, Wang Q, Lu YJ, Bao L, Zhang X (2011) Facilitation of μ-opioid receptor activity by preventing δ-opioid receptor-mediated codegradation. Neuron 69:120-131. CrossRef Medline
15. Jäntti MH, Mandrika I, Kukkonen JP (2014) Human orexin/hypocretin receptors form constitutive homo-and heteromeric complexes with each other and with human CB1 cannabinoid receptors. Biochem Biophys Res Commun 445:486-490. CrossRef Medline
16. Kita JM, Kile BM, Parker LE, Wightman RM (2009) In vivo measurement of somatodendritic release of dopamine in the ventral tegmental area. Synapse 63:951-960. CrossRef Medline
17. Kourrich S, Hayashi T, Chuang JY, Tsai SY, Su TP, Bonci A (2013) Dynamic interaction between sigma-1 receptor and Kvl.2 shapes neuronal and behavioral responses to cocaine. Cell 152:236-247. CrossRef Medline
18. Kovacs JJ, Hara MR, Davenport CL, Kim J, Lefkowitz RJ (2009) Arrestin development: emerging roles for beta-arrestins in developmental signaling pathways. Dev Cell 17:443-458. CrossRef Medline
19. Legault M, Wise RA (1999) Injections of N-methyl-D-aspartate into the ventral hippocampus increase extracellular dopamine in the ventral tegmental area and nucleus accumbens. Synapse 31:241-249. CrossRef Medline
20. Lodge DJ, Grace AA (2005) Acute and chronic corticotropin-releasing factor 1 receptor blockade inhibits cocaine-induced dopamine release: correlation with dopamine neuron activity. J Pharmacol Exp Ther 314:201-206. CrossRef Medline
21. Lu L, Liu Z, Huang M, Zhang Z (2003) Dopamine-dependent responses to cocaine depend on corticotropin-releasing factor receptor subtypes. J Neurochem 84:1378-1386. CrossRef Medline
22. Mahler SV, Moorman DE, Smith RJ, James MH, Aston-Jones G (2014) Motivational activation: a unifying hypothesis of orexin/hypocretin function. Nat Neurosci 17:1298-1303. CrossRef Medline
23. Maurice T, Su TP (2009) The pharmacology of sigma-1 receptors. Pharmacol Ther 124:195-206. CrossRef Medline
24. Mikhailova MV, Mayeux PR, Jurkevich A, Kuenzel WJ, Madison F, Periasamy A, Chen Y, Cornett LE (2007) Heterooligomerization between vasotocin and corticotropin-releasing hormone (CRH) receptors augments CRH-stimulated 3',5'-cyclic adenosine monophosphate production. Mol Endocrinol 21:2178-2188. CrossRef Medline
25. Milan-Lobo L, Gsandtner I, Gaubitzer E, Rünzler D, Buchmayer F, Köhler G, Bonci A, Freissmuth M, Sitte HH (2009) Subtype-specific differences in corticotropin-releasing factor receptor complexes detected by fluorescence spectroscopy. Mol Pharmacol 76:1196-1210. CrossRef Medline
26. Moreno E, Moreno-Delgado D, Navarro G, Hoffmann HM, Fuentes S, Rosell-Vilar S, Gasperini P, Rodríguez-Ruiz M, Medrano M, Mallol J, Cortés A, Casadó V, Lluís C, Ferré S, Ortiz J, Canela E, McCormick PJ (2014) Cocaine disrupts histamine H3 receptor modulation of dopamine D1 receptor signaling: σl-Dl-H3 receptor complexes as key targets for reducing cocaine's effects. J Neurosci 34:3545-3558. CrossRef Medline
27. Murat B, Devost D, Andrés M, Mion J, Boulay V, Corbani M, Zingg HH, Guillon G (2012) Vlb and CRHR1 receptor heterodimerization mediates synergistic biological actions of vasopressin and CRH. Mol Endocrinol 26:502-520. CrossRef Medline
28. Navarro G, Moreno E, Aymerich M, Marcellino D, McCormick PJ, Mallol J, Cortés A, Casadó V, Canela EI, Ortiz J, Fuxe K, Lluís C, Ferré S, Franco R (2010) Direct involvement of sigma 1 receptors in the dopamine D1 receptor-mediated effects of cocaine. Proc Natl Acad Sci USA 107: 18676-18681. CrossRef Medline
29. Navarro G, Moreno E, Bonaventura J, Brugarolas M, Farré D, Aguinaga D, Mallol J, Cortés A, Casadó V, Lluís C, Ferre S, Franco R, Canela E, McCormick PJ (2013) Cocaine inhibits dopamine D2 receptor signaling via sigma-1-D2 receptor heteromers. PLoS One 8:e61245. CrossRef Medline
30. Pettit HO, Pan HT, Parsons LH, Justice JB Jr (1990) Extracellular concentrations of cocaine and dopamine are enhanced during chronic cocaine administration. J Neurochem 55:798-804. CrossRef Medline
31. Richards JK, Simms JA, Steensland P, Taha SA, Borgland SL, Bonci A, Bartlett SE (2008) Inhibition of orexin-1/hypocretin-1 receptors inhibits yohimbine-induced reinstatement of ethanol and sucrose seeking in Long-Evans rats. Psychopharmacology 199:109-117. CrossRef Medline
32. Robson MJ, Noorbakhsh B, Seminerio MJ, Matsumoto RR (2012) Sigma-1 receptors: potential targets for the treatment of substance abuse. Curr Pharm Des 18:902-919. CrossRef Medline
33. Rodaros D, Caruana DA, Amir S, Stewart J (2007) Corticotropin-releasing factor projections from limbic forebrain and paraventricular nucleus of the hypothalamus to the region of the ventral tegmental area. Neuroscience 150:8-13. CrossRef Medline
34. Saal D, Dong Y, Bonci A, Malenka RC (2003) Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron 37:577-582. CrossRef Medline
35. Sakurai T (2014) The role of orexin in motivated behaviours. Nat Rev Neurosci 15:719-731. CrossRef Medline
36. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, Kozlowski GP, Wilson S, Arch JR, Buckingham RE, Haynes AC, Carr SA, Annan RS, McNulty DE, Liu WS, Terrett JA, Elshourbagy NA, Bergsma DJ, Yanagisawa M (1998) Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92:573-585. CrossRef Medline
37. Sarnyai Z, Shaham Y, Heinrichs SC (2001) The role of corticotropin-releasing factor in drug addiction. Pharmacol Rev 53:209-243. Medline
38. Schwarze SR, Ho A, Vocero-Akbani A, Dowdy SF (1999) In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285:1569-1572. CrossRef Medline
39. Shaham Y, Erb S, Leung S, Buczek Y, Stewart J (1998) CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor 1 receptor attenuates stress-induced relapse to drug seeking in cocaine-and heroin-trained rats. Psychopharmacology 137:184-190. CrossRef Medline
40. Ungless MA, Singh V, Crowder TL, Yaka R, Ron D, Bonci A (2003) Corticotropin-releasing factor requires CRF binding protein to potentiate NMDA receptors via CRF receptor 2 in dopamine neurons. Neuron 39: 401-407. CrossRef Medline
41. Wang B, Shaham Y, Zitzman D, Azari S, Wise RA, You ZB (2005) Cocaine experience establishes control of midbrain glutamate and dopamine by corticotropin-releasing factor: a role in stress-induced relapse to drug seeking. J Neurosci 25:5389-5396. CrossRef Medline
42. Wang B, You ZB, Rice KC, Wise RA (2007) Stress-induced relapse to cocaine seeking: roles for the CRF (2) receptor and CRF-binding protein in the ventral tegmental area of the rat. Psychopharmacology 193:283-294. CrossRef Medline
43. Wang B, You ZB, Wise RA (2009) Reinstatement of cocaine seeking by hypocretin (orexin) in the ventral tegmental area: independence from the local corticotropin-releasing factor network. Biol Psychiatry 65:857-862. CrossRef Medline